Phuc Le

1.3k total citations · 1 hit paper
58 papers, 751 citations indexed

About

Phuc Le is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Hepatology. According to data from OpenAlex, Phuc Le has authored 58 papers receiving a total of 751 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Epidemiology, 21 papers in Endocrinology, Diabetes and Metabolism and 10 papers in Hepatology. Recurrent topics in Phuc Le's work include Liver Disease Diagnosis and Treatment (13 papers), Diabetes Treatment and Management (12 papers) and Herpesvirus Infections and Treatments (8 papers). Phuc Le is often cited by papers focused on Liver Disease Diagnosis and Treatment (13 papers), Diabetes Treatment and Management (12 papers) and Herpesvirus Infections and Treatments (8 papers). Phuc Le collaborates with scholars based in United States, Vietnam and United Kingdom. Phuc Le's co-authors include Michael B. Rothberg, Naim Alkhouri, William H. Herman, Abhishek Deshpande, Elizabeth R. Pfoh, Hamlet Gasoyan, Wen Ye, Anita D. Misra‐Hebert, Alexander Chaitoff and Srinivasan Dasarathy and has published in prestigious journals such as Annals of Internal Medicine, Gastroenterology and American Journal of Psychiatry.

In The Last Decade

Phuc Le

53 papers receiving 732 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Estimated Burden of Metabolic Dysfunction–Associated Steatotic Liver Disease in US Adults, 2020 to 2050

2025 55 citations Phuc Le, Moosa Tatar et al. JAMA Network Open profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Phuc Le United States	16	462	228	106	91	78	58	751
Caroline Minassian United Kingdom	13	421 0.9×	302 1.3×	10 0.1×	58 0.6×	46 0.6×	22	977
Jussi Sutinen Finland	25	503 1.1×	252 1.1×	123 1.2×	103 1.1×	22 0.3×	48	1.8k
José Mayo Spain	16	208 0.5×	84 0.4×	27 0.3×	116 1.3×	42 0.5×	33	639
Chiu-Ching Huang Taiwan	14	183 0.4×	58 0.3×	94 0.9×	43 0.5×	14 0.2×	21	596
Prayong Vachvanichsanong Thailand	17	161 0.3×	39 0.2×	33 0.3×	80 0.9×	46 0.6×	58	838
Yao‐Lung Liu Taiwan	17	189 0.4×	28 0.1×	57 0.5×	125 1.4×	11 0.1×	30	698
Sergio Reus Spain	14	291 0.6×	36 0.2×	69 0.7×	41 0.5×	11 0.1×	64	633
Bart G.P. Koot Netherlands	23	617 1.3×	275 1.2×	210 2.0×	402 4.4×	9 0.1×	76	1.3k
Katayoun Vahdat Iran	16	207 0.4×	69 0.3×	24 0.2×	174 1.9×	15 0.2×	60	716
G. J. Krejs Austria	14	92 0.2×	119 0.5×	28 0.3×	173 1.9×	30 0.4×	33	515

Countries citing papers authored by Phuc Le

Since Specialization

Citations

This map shows the geographic impact of Phuc Le's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phuc Le with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phuc Le more than expected).

Fields of papers citing papers by Phuc Le

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phuc Le. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phuc Le. The network helps show where Phuc Le may publish in the future.

Co-authorship network of co-authors of Phuc Le

This figure shows the co-authorship network connecting the top 25 collaborators of Phuc Le. A scholar is included among the top collaborators of Phuc Le based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phuc Le. Phuc Le is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vo, Quoc, et al.. (2025). Burden and risk factors of Alzheimer's disease and other dementias in Vietnam from 1990 to 2021 – A comprehensive analysis from global burden disease. PubMed. 9. 100390–100390. 2 indexed citations

Gasoyan, Hamlet, W. Scott Butsch, H. Renner, et al.. (2025). Reasons for Discontinuation of Obesity Pharmacotherapy With Semaglutide or Tirzepatide in Clinical Practice. Obesity. 33(12). 2296–2303. 1 indexed citations

Le, Phuc, et al.. (2025). Socio‐demographic and clinical factors associated with the receipt of anti‐obesity medication prescriptions and metabolic and bariatric surgery among eligible all of Us participants. Diabetes Obesity and Metabolism. 27(9). 4978–4988. 2 indexed citations

Gasoyan, Hamlet, W. Scott Butsch, Phuc Le, et al.. (2025). Changes in weight and glycemic control following obesity treatment with semaglutide or tirzepatide by discontinuation status. Obesity. 33(9). 1657–1667. 9 indexed citations

Le, Phuc, Moosa Tatar, Michael B. Rothberg, et al.. (2025). Association of Components of Metabolic Syndrome and the Progression of Nonalcoholic Fatty Liver Disease. The American Journal of Gastroenterology. 121(1). 159–170.

Gasoyan, Hamlet, et al.. (2024). One-Year Weight Reduction With Semaglutide or Liraglutide in Clinical Practice. JAMA Network Open. 7(9). e2433326–e2433326. 25 indexed citations

Gasoyan, Hamlet, et al.. (2024). Association of patient characteristics and insurance type with anti‐obesity medications prescribing and fills. Diabetes Obesity and Metabolism. 26(5). 1687–1696. 15 indexed citations

Alkhouri, Naim, et al.. (2024). The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD)-related advanced fibrosis and cirrhosis in the United States population utilizing AGILE 3 + and AGILE 4 scores: analysis of the NHANES 2017–2018 cycle. BMC Gastroenterology. 24(1). 218–218. 5 indexed citations

Alkhouri, Naim, et al.. (2023). Prevalence of at-risk NASH and its association with metabolic syndrome in US adults with NAFLD, 2017–2018. Hepatology Communications. 7(1). e0019–e0019. 21 indexed citations

10.

Gasoyan, Hamlet, et al.. (2023). Early‐ and later‐stage persistence with antiobesity medications: A retrospective cohort study. Obesity. 32(3). 486–493. 44 indexed citations

11.

Le, Phuc, et al.. (2022). Trends in Use of High-Cost Antihyperglycemic Drugs Among US Adults with Type 2 Diabetes. Journal of General Internal Medicine. 38(1). 49–56. 2 indexed citations

12.

Le, Phuc, et al.. (2022). Adherence to the American Diabetes Association’s Glycemic Goals in the Treatment of Diabetes Among Older Americans, 2001–2018. Diabetes Care. 45(5). 1107–1115. 10 indexed citations

13.

Alkhouri, Naim, et al.. (2022). The prevalence of alcoholic and nonalcoholic fatty liver disease in adolescents and young adults in the United States: analysis of the NHANES database. BMC Gastroenterology. 22(1). 366–366. 29 indexed citations

14.

Le, Phuc, et al.. (2021). COVID-19 Pandemic, Stimulus Packages and Stock Returns in Vietnam. Journal of Economics and Business. 4(2).

15.

Le, Phuc, Alexander Chaitoff, Anita D. Misra‐Hebert, et al.. (2020). Use of Antihyperglycemic Medications in U.S. Adults: An Analysis of the National Health and Nutrition Examination Survey. Diabetes Care. 43(6). 1227–1233. 57 indexed citations

16.

Sultan, Assem A., William A. Cantrell, Linsen T. Samuel, et al.. (2020). Removal of a urinary catheter before discontinuation of epidural analgesia is associated with an increased risk of postoperative urinary retention and hospital episode costs in patients undergoing surgical correction for adolescent idiopathic scoliosis. Spine Deformity. 8(2). 195–201.

17.

Misra‐Hebert, Anita D., Bo Hu, Phuc Le, & Michael B. Rothberg. (2017). Effect of Health Plan Financial Incentive Offering on Employees with Prediabetes. The American Journal of Medicine. 131(3). 293–299. 2 indexed citations

18.

Le, Phuc & Michael B. Rothberg. (2017). Cost Effectiveness of a Shingles Vaccine Booster for Currently Vaccinated Adults in the U.S.. American Journal of Preventive Medicine. 53(6). 829–836. 9 indexed citations

19.

Le, Phuc. (2016). HOW MUCH IS IT WORTH TO PREVENT SHINGLES? USING COST-EFFECTIVENESS ANALYSIS TO DETERMINE VALUE-BASED PRICING OF A NEW HERPES ZOSTER VACCINE. 2 indexed citations

20.

Le, Phuc. (2015). DETERMINING THE OPTIMAL AGE TO VACCINATE AGAINST HERPES ZOSTER: A COST-EFFECTIVENESS ANALYSIS. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact